Pharmacology & ToxicologybioRxivPreprint
Shifting KRAS hotspot mutations inhibition paradigm in colorectal cancer
Ana Rita Brás, Ana Lopes, Nuno M. Mendes…·Ana Preto
This study identifies a ruthenium compound, PMC79, that selectively inhibits KRAS mutations in colorectal cancer and enhances chemotherapy efficacy.
1 citation